p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation.
about
Pliable DNA Conformation of Response Elements Bound to Transcription Factor p63Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells.Mutant p53 cooperates with the SWI/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cellsPioneer transcription factors in cell reprogramming.TP53 engagement with the genome occurs in distinct local chromatin environments via pioneer factor activityRe-engineered p53 activates apoptosis in vivo and causes primary tumor regression in a dominant negative breast cancer xenograft model.Mechanism of N-Acylthiourea-mediated activation of human histone deacetylase 8 (HDAC8) at molecular and cellular levels.Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53Special AT-rich binding protein-2 (SATB2) differentially affects disease-causing p63 mutant proteins.p53-Dependent induction of PVT1 and miR-1204.The Spindle Assembly Checkpoint Safeguards Genomic Integrity of Skeletal Muscle Satellite Cells.TFIIB dephosphorylation links transcription inhibition with the p53-dependent DNA damage responseCarcinogenic polycyclic aromatic hydrocarbons induce CYP1A1 in human cells via a p53-dependent mechanism.Rotational positioning of nucleosomes facilitates selective binding of p53 to response elements associated with cell cycle arrest.H1 and HMGB1: modulators of chromatin structure.Quantitative Analysis of the DNA Methylation Sensitivity of Transcription Factor Complexes.Loss of DAB2IP in RCC cells enhances their growth and resistance to mTOR-targeted therapies.Parallel profiling of the transcriptome, cistrome, and epigenome in the cellular response to ionizing radiation.Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.Nrf2 activation is associated with Z-DNA formation in the human HO-1 promoter.Thyroid hormone suppresses cell proliferation through endoglin-mediated promotion of p21 stability.MdmX is required for p53 interaction with and full induction of the Mdm2 promoter after cellular stress.Doxorubicin enhances nucleosome turnover around promoters.The p53-HAT connection: PCAF rules?Oligosaccharide G19 inhibits U-87 MG human glioma cells growth in vitro and in vivo by targeting epidermal growth factor (EGF) and activating p53/p21 signaling.A DNA Structural Alphabet Distinguishes Structural Features of DNA Bound to Regulatory Proteins and in the Nucleosome Core Particle.p53 binding sites in normal and cancer cells are characterized by distinct chromatin context.Mechanisms of transcriptional regulation by p53.Necessity of p53-binding to the CDH1 locus for its expression defines two epithelial cell types differing in their integrity.FAM188B enhances cell survival via interaction with USP7.The p53 C terminus controls site-specific DNA binding and promotes structural changes within the central DNA binding domain
P2860
Q27676758-DC05A7C4-C275-4F57-AC48-F78CED986B02Q33708609-B05F19A0-AFB2-41C8-AA94-BB6EC0106917Q34480997-DE619191-FCC7-40E4-86F1-4F5B7B9ADC7EQ34697693-B036784F-9C86-4826-8A6F-450472AD4640Q35042948-4E45EFD3-0521-4AB5-92CC-BBF2F69C3F19Q35073239-324D0BCE-AE71-4C9C-B688-3251F9E2CF16Q35173031-22B05CF2-4011-4B2F-9500-9120D42D4492Q35196159-CA8792FD-4E96-4A7E-8958-04D359500552Q35562528-BF211F14-3106-49A6-A074-F39B28EF72CDQ35709920-011BFA21-3CBD-4904-B272-0DFAB4EEFEBEQ35754387-5DAFEB18-2EE2-4B36-BC2E-8F5875C27DD9Q36414906-747CB37D-0D95-42E7-A1D3-C7CC49FDFFACQ36564307-4FEDAEBF-3C35-4AC5-AFF5-26C132E930B2Q37518662-18809144-5541-4413-B116-0EA2B27EF757Q37995719-A07948C6-7908-4196-9647-44E5C9AA98FDQ38725653-9BB3EA41-0865-4C55-8451-736AAAEB70FDQ38794217-418E1FB8-3618-40AA-8CC8-65755CA79049Q38995173-F753273F-3D4E-45D8-AD5F-AACF749A4E2BQ39005896-BC088CED-2A1B-4E84-9237-F6138145D734Q39168811-1E4130C7-6EBC-4475-96CB-2CEE32779CC3Q39200344-4CE0AC16-900A-4663-89E0-DC68B39AB05DQ39404029-FB3FEF02-28B1-4406-A071-C172917088FBQ42149656-9895DBB2-6585-45A2-BF33-F4BAC4D152C4Q42325497-9E98FFA0-9689-4110-A6E6-09BAF3F5FD23Q46897628-917DB663-E9C4-4E74-AFF6-6DEE349C62C4Q47106883-CB495280-2FEF-415C-97C7-44D4C5866782Q47140890-310DDB10-759E-4ED7-B84B-507E31A36823Q47416965-C4FC37AC-28FE-4DBB-9A86-1B4F32E49338Q48162761-5F59F974-7833-4DD2-903F-81AC58F17C77Q55014034-0D03F319-6C2C-4032-ADD1-07C49E11A3F5Q58430752-4ADCF63E-DACA-4400-A53F-A1C6A6C4EF96
P2860
p53 binding to nucleosomes within the p21 promoter in vivo leads to nucleosome loss and transcriptional activation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
p53 binding to nucleosomes wit ...... nd transcriptional activation.
@ast
p53 binding to nucleosomes wit ...... nd transcriptional activation.
@en
type
label
p53 binding to nucleosomes wit ...... nd transcriptional activation.
@ast
p53 binding to nucleosomes wit ...... nd transcriptional activation.
@en
prefLabel
p53 binding to nucleosomes wit ...... nd transcriptional activation.
@ast
p53 binding to nucleosomes wit ...... nd transcriptional activation.
@en
P2093
P2860
P356
P1476
p53 binding to nucleosomes wit ...... nd transcriptional activation.
@en
P2093
Carol Prives
Ella Freulich
Oleg Laptenko
Rachel Beckerman
P2860
P304
10385-10390
P356
10.1073/PNAS.1105680108
P407
P577
2011-05-23T00:00:00Z